Rapport Therapeutics, Inc. (RAPP)
40.81
-1.14
(-2.72%)
USD |
NASDAQ |
Sep 18, 13:09
Rapport Therapeutics Total Liabilities (Quarterly) : 36.06M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.06M |
| March 31, 2026 | 26.08M |
| December 31, 2025 | 27.78M |
| September 30, 2025 | 23.71M |
| June 30, 2025 | 21.98M |
| March 31, 2025 | 16.22M |
| Date | Value |
|---|---|
| December 31, 2024 | 9.506M |
| September 30, 2024 | 8.03M |
| June 30, 2024 | 9.212M |
| March 31, 2024 | 11.18M |
| December 31, 2023 | 14.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 458.98M |
| Shareholders Equity (Quarterly) | 422.93M |
| Debt to Equity Ratio | 0.0239 |
| Current Ratio | 15.72 |
| Net Debt Paydown Yield | -0.02% |